|
Manufacturer's investigation conclusion: evidence of an oxygenator leak consistent with fiber breakage was confirmed through evaluation of the returned oxygenator and submitted photo; however, a specific root cause for this finding could not be conclusively determined through this evaluation.Evaluation of the submitted image confirmed blood on the bottom of the oxygenator that appeared to have dripped from the bottom of the orange housing.The oxygenator was returned to abbott where an initial visual inspection was performed.Visual inspection of the oxygenator revealed no obvious damage; however, dried blood was noted at the bottom of the fiber bundle and in the bottom orange housing, within the gas flow pathway.The oxygenator was unable to be forwarded to the external manufacturer (eurosets) for technical analysis due to eurosets¿ internal procedures.The returned oxygenator was pressurized to approximately 850 millimeters of mercury (mmhg), and no leak was detected.The oxygenator was then operated on a test loop for approximately 10 minutes at 5000 revolutions per minute and approximately 0.7 liters per minute, with an inlet pressure of approximately 550 mmhg and an outlet pressure of approximately 1 mmhg.No leak was detected.The flow and pressure values recorded appeared consistent with post-exchange clotting or drying of the blood that remained in the returned device.Although the leak was unable to be reproduced through testing, the finding of dried blood within the bottom housing appeared consistent with a leak due to a broken fiber.The production documentation for eurosets was reviewed by the external manufacturer (eurosets) and showed that all tests from the production process were compliant with technical specifications.Devices are required to pass manufacturing inspections and specifications prior to release, and no abnormalities were documented which would cause or contribute to the reported occurrence.Devices that exhibit leaks are discarded prior to distribution.Eurosets determined that the issue occurred after eurosets¿ manufacturing and test phases.Eurosets communicated that their production process and controls will continue to be improved to further reduce the occurrence rate of these events.This event will also be monitored within the eurosets trend reporting and in case of adverse trends, further investigation and/or corrective actions will be carried out.The production documentation for eurosets amg pmp oxygenator, lot #106021028, was reviewed by the external manufacturer (eurosets) and showed that all tests from the production process were compliant with technical specifications.The eurosets amg pmp instructions for use (ifu) is currently available.Under the list of warnings, the ifu warns that during use, a spare oxygenator must always be available and also warns that the device has to be carefully and continuously checked by qualified healthcare professionals throughout the procedure.The ifu warns to carefully check the device seal during priming and operation.Any loss may result in contamination of the environment or the operator, loss of blood, air embolism.If you notice leakage during priming or operation, replace the defective device following good perfusion practices.Also, under the section titled ¿set up¿, the ifu warns to ¿carry out a visual inspection and carefully check the device before use.Transport and/or storage conditions other than those prescribed may have caused damage to the device.¿ under the section titled ¿during bypass¿, the ifu instructs that during the entire procedure, according to good prefusion practices, monitor the integrity of the system for leaks absence.In this section, the ifu warns that ¿during cpb (cardiopulmonary bypass) check the oxygenator integrity, a small breach can also result in continuous blood loss, bacterial risk, viral infection or pyrogen reaction.A large breach can result in rapid blood loss leading to shock and death.If leakage occurs replace the oxygenator with a new one.¿ under the section titled ¿oxygenator replacement¿, this document states that a spare oxygenator must always be available during perfusion.After 6 hours of use with blood or if particular situations occur, which may lead the person responsible for perfusion to determine the safety of the patient may be compromised (insufficient oxygenator performance, leaks, abnormal blood parameters, etc.), follow the procedure outlined in the ifu for oxygenator replacement.No further information was provided.The manufacturer is closing the file on this event.
|